Chargement en cours...
Inflammatory bowel disease surgery in the biologic era
Anti-tumour necrosis factor (TNF)-α therapy has revolutionized inflammatory bowel disease (IBD) treatment. Infliximab and adalimumab either as monotherapy or in combination with an immunomodulator are able to induce clinical and biological remission in patients with moderate and severe Crohn’s disea...
Enregistré dans:
| Publié dans: | World J Gastrointest Surg |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872064/ https://ncbi.nlm.nih.gov/pubmed/27231514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v8.i5.363 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|